methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

methamphetamine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 39 studies

Research

Studies (39)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (10.26)	18.7374
1990's	12 (30.77)	18.2507
2000's	20 (51.28)	29.6817
2010's	3 (7.69)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, J; Conway, SJ; Ganapathy, V; Huang, W; Leibach, FH; Prasad, PD; Rajan, DP; Seth, P; Wu, X	1
Heikkila, RE; Nicklas, WJ; Sonsalla, PK	1
Heikkila, RE; Sonsalla, PK	1
DeLanney, LE; Forno, LS; Irwin, I; Langston, E; Langston, JW; Ricaurte, GA	1
Jarvis, MF; Wagner, GC	1
Bassi, L; Corsini, GU; Fornai, F; Scalori, V; Torracca, MT	1
Budai, G; Kardos, V; Pátfalusi, M; Patthy, M; Sziráki, I	1
Albers, DS; Sonsalla, PK; Zeevalk, GD	1
Hall, ED; Jochnowitz, ND; Oostveen, JA; Sonsalla, PK; Zeevalk, GD	1
Ali, SF; Itzhak, Y; Martin, JL; Norenberg, MD	1
Corsini, GU; Fornai, F; Maggio, R; Racagni, G; Riva, M; Vaglini, F	1
Albers, DS; Moy, LY; Sonsalla, PK	1
Ali, SF; Laws, SC; Miller, DB; O'Callaghan, JP	1
Green, S; Jakowec, MW; Petzinger, GM; Tolwani, RJ; Waggie, K	1
Hastings, TG; LaVoie, MJ	1
Ali, SF; Black, MD; Itzhak, Y; Martin, JL	1
Chancy, CD; Ganapathy, V; Huang, W; Kekuda, R; Rajan, PD; Smith, SB	1
Bing, G; Jhoo, W; Kim, H; Shin, E	1
Hogan, KA; Sonsalla, PK; Staal, RG	1
Benkovic, S; Gordon, MN; Miller, D; O'Callaghan, JP; Pennypacker, KR; Yang, X	1
Cadet, JL	1
Dryhurst, G	1
Battaglia, G; Busceti, CL; Fornai, F; Gesi, M; Lenzi, P; Nicoletti, F; Orzi, F; Rampello, L; Ruggieri, S; Soldani, P	1
Kita, T; Konishi, N; Matsunari, Y; Nakamura, M; Nakashima, T; O'Hara, K; Saraya, T; Shimada, K; Wagner, GC	1
Battaglia, G; Busceti, CL; De Blasi, A; Fornai, F; Lembo, G; Nicoletti, F	1
Halász, AS; Magyar, K; Pálfi, M; Szöko, E; Tábi, T	2
Binienda, Z; Gaetani, F; Virmani, A	1
Miller, DB; O'Callaghan, JP; Sriram, K	2
Brown, JM; Cox, BM; Gouty, S; Iyer, V; Rosenberger, J	1
Bandettini Di Poggio, A; De Blasi, A; Fornai, F; Lazzeri, G; Nicoletti, F; Paparelli, A; Ruggieri, S; Soldani, P	1
Ali, SF; Lyn-Cook, B; Robinson, B; Tareke, E	1
Fornai, F; Paparelli, A; Pasquali, L; Ruffoli, R; Ruggieri, S; Soldani, P	1
Fornai, F; Kastsiuchenka, O; Natale, G; Paparelli, A; Pasquali, L; Ruggieri, S	1
Bourque, M; Di Paolo, T; Dluzen, DE	1
Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; Quiñones-Hinojosa, A; Shah, A	1
Dagda, RK; Das Banerjee, T; Janda, E	1
Angoa-Pérez, M; Anneken, JH; Kuhn, DM	1

Reviews

7 review(s) available for methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
Experimental models of Parkinson's disease: insights from many models. Laboratory animal science, 1999, Volume: 49, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reserpine	1999
Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice. Parkinsonism & related disorders, 2001, Volume: 8, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methamphetamine; Mice; Mice, Knockout; Mice, Transgenic; Neurotoxins; Oxidopamine; Parkinsonian Disorders	2001
Are dopamine, norepinephrine, and serotonin precursors of biologically reactive intermediates involved in the pathogenesis of neurodegenerative brain disorders? Advances in experimental medicine and biology, 2001, Volume: 500 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; Dopamine; Dopamine Uptake Inhibitors; Glutathione; Humans; Methamphetamine; Nervous System; Neurodegenerative Diseases; Norepinephrine; Protein Precursors; Reperfusion Injury; Serotonin	2001
Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine. Annals of the New York Academy of Sciences, 2005, Volume: 1053 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites; Antioxidants; Carnitine; Central Nervous System Stimulants; Coenzymes; Energy Metabolism; Fatty Acids, Unsaturated; Glucose; Humans; Methamphetamine; Neurodegenerative Diseases; Neuroprotective Agents; Oxidative Stress; Ubiquinone	2005
Neuroprotective actions of sex steroids in Parkinson's disease. Frontiers in neuroendocrinology, 2009, Volume: 30, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Dopamine Agents; Estrogens; Humans; Methamphetamine; Mitogen-Activated Protein Kinases; Neural Pathways; Neuroprotective Agents; Parkinson Disease; Phosphatidylinositol 3-Kinases; Progesterone; Receptors, Estrogen; Sex Characteristics; Signal Transduction; Steroids	2009
Animal models of neurological disease. Advances in experimental medicine and biology, 2010, Volume: 671 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents	2010
How Parkinsonian toxins dysregulate the autophagy machinery. International journal of molecular sciences, 2013, Nov-08, Volume: 14, Issue:11 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Autophagy; Humans; Methamphetamine; Mitophagy; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinsonian Disorders; Rotenone	2013

Other Studies

32 other study(ies) available for methamphetamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Article	Year
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. The Journal of pharmacology and experimental therapeutics, 1999, Volume: 290, Issue:3 Topics: Acetylcarnitine; Animals; Biological Transport, Active; Carnitine; Carrier Proteins; Humans; In Situ Hybridization; Kidney; Membrane Proteins; Mice; Myocardium; Organ Specificity; Organic Cation Transport Proteins; Placenta; Rats; RNA, Messenger; Solute Carrier Family 22 Member 5; Tetraethylammonium	1999
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (New York, N.Y.), 1989, Jan-20, Volume: 243, Issue:4889 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amino Acids; Animals; Corpus Striatum; Dibenzocycloheptenes; Dizocilpine Maleate; Dopamine; Ketamine; Methamphetamine; Mice; Neurotoxins; Phencyclidine; Pyridines; Substantia Nigra; Tyrosine 3-Monooxygenase	1989
Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice. Progress in neuro-psychopharmacology & biological psychiatry, 1988, Volume: 12, Issue:2-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neurotoxins; Pyridines; Species Specificity	1988
Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra. Brain research, 1987, Feb-10, Volume: 403, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Degeneration; Pyridines; Substantia Nigra	1987
Neurochemical and functional consequences following 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) and methamphetamine. Life sciences, 1985, Jan-21, Volume: 36, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Female; Male; Methamphetamine; Pargyline; Pyridines; Rats; Rats, Inbred Strains; Serotonin; Species Specificity	1985
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice. European journal of pharmacology, 1995, Sep-05, Volume: 283, Issue:1-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Frontal Lobe; Locus Coeruleus; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Serotonin; Time Factors	1995
Methamphetamine protects against MPTP neurotoxicity in C57BL mice. European journal of pharmacology, 1994, Jan-14, Volume: 251, Issue:2-3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Brain Diseases; Corpus Striatum; Dopamine; Male; Methamphetamine; Mice; Mice, Inbred C57BL; MPTP Poisoning; Neurons	1994
Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP. Brain research, 1996, Apr-29, Volume: 718, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Energy Metabolism; Male; Malonates; Methamphetamine; Mice; Neostriatum; Nerve Endings; Tyrosine 3-Monooxygenase	1996
Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain research, 1996, Oct-28, Volume: 738, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Corpus Striatum; Dopamine; Dopamine Agents; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Substantia Nigra; Tyrosine 3-Monooxygenase	1996
Depletion of striatal dopamine transporter does not affect psychostimulant-induced locomotor activity. Neuroreport, 1997, Oct-20, Volume: 8, Issue:15 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Central Nervous System Stimulants; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kinetics; Male; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Motor Activity; Neostriatum; Nerve Tissue Proteins; Protein Binding	1997
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. Journal of neural transmission (Vienna, Austria : 1996), 1997, Volume: 104, Issue:10 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain-Derived Neurotrophic Factor; Cells, Cultured; Dopamine Uptake Inhibitors; Fibroblast Growth Factor 2; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred C57BL; Neostriatum; Neuroprotective Agents; Neurotoxins; Nicotine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tyrosine 3-Monooxygenase	1997
Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Brain research, 1998, Apr-20, Volume: 790, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Body Temperature; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Methamphetamine; Mice; MPTP Poisoning; Nerve Degeneration; Neurons; Neurotoxins; Serotonin Receptor Agonists; Tyrosine 3-Monooxygenase	1998
The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Annals of the New York Academy of Sciences, 1998, May-30, Volume: 844 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Corpus Striatum; Dopamine; Estradiol; Female; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Organ Size; Ovariectomy; Sex Characteristics; Uterus	1998
Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. Journal of neurochemistry, 1999, Volume: 73, Issue:6 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alcohol Dehydrogenase; Antioxidants; Apoptosis; Catalase; Chromatography, High Pressure Liquid; Dopamine; Hydrogen-Ion Concentration; Methamphetamine; Monophenol Monooxygenase; Nerve Tissue Proteins; Neurons; Nitrates; Nitric Oxide; Nitrites; Oxidants; Oxidation-Reduction; Parkinson Disease; Protein Binding; Sulfhydryl Compounds; Superoxide Dismutase	1999
Neuroprotective role of melatonin in methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity. Annals of the New York Academy of Sciences, 1999, Volume: 890 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Fever; Free Radical Scavengers; Melatonin; Methamphetamine; Mice; Neuroprotective Agents	1999
Expression of the extraneuronal monoamine transporter in RPE and neural retina. Current eye research, 2000, Volume: 20, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Amphetamine; Animals; Biogenic Monoamines; Blotting, Northern; Carrier Proteins; Cells, Cultured; Eye; Female; Gene Expression; Humans; Hydrogen-Ion Concentration; In Situ Hybridization; Kinetics; Methamphetamine; Mice; Mice, Inbred ICR; Nicotine; Organic Cation Transport Proteins; Pigment Epithelium of Eye; Procainamide; Retina; RNA, Messenger; Steroids; Tetraethylammonium; Time Factors	2000
Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model. Brain research, 2000, Apr-17, Volume: 862, Issue:1-2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antioxidants; Diet; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neurons; Selenium; Substantia Nigra; Tyrosine 3-Monooxygenase	2000
Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations. Journal of neurochemistry, 2000, Volume: 74, Issue:5 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Histological Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neuropeptides; Synaptic Vesicles; Synaptosomes; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins	2000
Long-term induction of Fos-related antigen-2 after methamphetamine-, methylenedioxymethamphetamine-, 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine- and trimethyltin-induced brain injury. Neuroscience, 2000, Volume: 101, Issue:4 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Diseases; DNA-Binding Proteins; Dopamine Agents; Fos-Related Antigen-2; Immunohistochemistry; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Sprague-Dawley; Time Factors; Transcription Factors; Trimethyltin Compounds	2000
Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity. Annals of the New York Academy of Sciences, 2002, Volume: 965 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Body Temperature; Catecholamines; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Immunohistochemistry; Kinetics; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Norepinephrine; Serotonin; Tyrosine 3-Monooxygenase	2002
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine pretreatment attenuates methamphetamine-induced dopamine toxicity. Pharmacology & toxicology, 2003, Volume: 92, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Antagonism; Glial Fibrillary Acidic Protein; Hypothermia; Immunohistochemistry; Injections, Subcutaneous; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Time Factors; Tyrosine 3-Monooxygenase	2003
Alpha-1B adrenergic receptor knockout mice are protected against methamphetamine toxicity. Journal of neurochemistry, 2003, Volume: 86, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Behavior, Animal; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Cytoprotection; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gliosis; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Mice, Knockout; Microdialysis; Motor Activity; MPTP Poisoning; Nerve Tissue Proteins; Prazosin; Receptors, Adrenergic, alpha-1; Tyrosine 3-Monooxygenase	2003
Altered nitric oxide production in mouse brain after administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridin or methamphetamine. Neurochemistry international, 2004, Volume: 44, Issue:8 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Brain Chemistry; Central Nervous System Stimulants; Dopamine Agents; Hippocampus; Injections, Intraperitoneal; Male; Methamphetamine; Mice; Neostriatum; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Peroxynitrous Acid	2004
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. Journal of neurochemistry, 2006, Volume: 96, Issue:3 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Count; Chemokine CCL2; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Interactions; Glial Fibrillary Acidic Protein; Homovanillic Acid; Interleukin-6; Male; Methamphetamine; Mice; Mice, Mutant Strains; Microglia; Minocycline; Neurons; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Time Factors; Tyrosine 3-Monooxygenase	2006
Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression. Journal of neurochemistry, 2006, Volume: 98, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Animals; Blotting, Western; Cell Survival; Cells, Cultured; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Female; Gene Deletion; Image Processing, Computer-Assisted; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Knockout; Neurons; Protein Precursors; Receptors, Opioid; Reverse Transcriptase Polymerase Chain Reaction; Sex Characteristics	2006
[Change of the nitric oxide synthase activity after administration of neurotoxic compounds in mice]. Acta pharmaceutica Hungarica, 2006, Volume: 76, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Citrulline; Corpus Striatum; Hippocampus; Methamphetamine; Mice; Mice, Inbred Strains; NADP; Neurotoxins; Nitric Oxide Synthase	2006
Convergent roles of alpha-synuclein, DA metabolism, and the ubiquitin-proteasome system in nigrostriatal toxicity. Annals of the New York Academy of Sciences, 2006, Volume: 1074 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Animals; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Methamphetamine; Neurotoxins; Parkinsonian Disorders; PC12 Cells; Proteasome Endopeptidase Complex; Rats; Substantia Nigra; Ubiquitin	2006
Acrylamide: a dietary carcinogen formed in vivo? Journal of agricultural and food chemistry, 2008, Aug-13, Volume: 56, Issue:15 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acrylamide; Animals; Carcinogens; Diet; Ferrous Compounds; Food Analysis; Food Handling; Globins; Hemoglobins; Hot Temperature; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Valine	2008
Defining "neuroinflammation". Annals of the New York Academy of Sciences, 2008, Volume: 1139 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Bacterial Agents; Antibodies, Phospho-Specific; Brain; Chemokines; Cytokines; Dopamine; Glial Fibrillary Acidic Protein; Gliosis; Humans; Inflammation; Methamphetamine; Mice; Mice, Inbred C57BL; Minocycline; Neurotoxins; NF-kappa B; Receptors, Tumor Necrosis Factor; Signal Transduction; Tyrosine 3-Monooxygenase	2008
Methamphetamine fails to alter the noradrenergic integrity of the heart. Annals of the New York Academy of Sciences, 2008, Volume: 1139 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Animals; Denervation; Dopamine Agonists; Heart; Humans; Hypotension, Orthostatic; Levodopa; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurotoxins; Norepinephrine; Parkinson Disease	2008
MPTP- but not methamphetamine-induced parkinsonism extends to catecholamine neurons in the gut. Annals of the New York Academy of Sciences, 2008, Volume: 1139 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Catecholamines; Dopamine Agents; Gastrointestinal Tract; Male; Methamphetamine; Mice; Mice, Inbred C57BL; Neurons; Neurotoxins; Parkinson Disease, Secondary; Random Allocation	2008
3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter. Journal of neurochemistry, 2015, Volume: 133, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzodioxoles; Body Temperature; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Female; Glial Fibrillary Acidic Protein; Methamphetamine; Mice; Mice, Inbred C57BL; Nerve Endings; Neurotoxins; Psychotropic Drugs; Pyrrolidines; Synthetic Cathinone; Tyrosine 3-Monooxygenase	2015